AstraZeneca (AZN)

Add to Watchlists
Create an Alert
34.44 -0.18  -0.52% NYSE Oct 23, 15:00 Delayed 2m USD

AstraZeneca Cash from Investing (Quarterly):

-205.00M for June 30, 2017
View 4,000+ financial data types
Browse...
View Full Chart

AstraZeneca Cash from Investing (Quarterly) Chart

Export Data
Save Image
Print Image

AstraZeneca Historical Cash from Investing (Quarterly) Data

View and export this data going back to 2000. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2017 -205.00M
March 31, 2017 -146.00M
Dec. 31, 2016 603.00M
Sept. 30, 2016 -624.00M
June 30, 2016 -1.061B
March 31, 2016 -2.887B
Dec. 31, 2015 -2.585B
Sept. 30, 2015 -420.00M
June 30, 2015 -678.00M
March 31, 2015 -556.00M
Dec. 31, 2014 -1.516B
Sept. 30, 2014 -561.00M
June 30, 2014 -1.178B
March 31, 2014 -3.777B
Dec. 31, 2013 -1.004B
Sept. 30, 2013 -647.00M
June 30, 2013 -874.00M
March 31, 2013 -364.00M
Dec. 31, 2012 -514.00M
Sept. 30, 2012 -2.698B
June 30, 2012 760.00M
March 31, 2012 593.00M
Dec. 31, 2011 -3.58B
Sept. 30, 2011 1.272B
June 30, 2011 186.00M
   
March 31, 2011 100.00M
Dec. 31, 2010 -452.00M
Sept. 30, 2010 258.00M
June 30, 2010 -925.00M
March 31, 2010 -1.107B
Dec. 31, 2009 -1.904B
Sept. 30, 2009 -410.00M
June 30, 2009 -236.00M
March 31, 2009 74.00M
Dec. 31, 2008 -472.00M
Sept. 30, 2008 -225.00M
June 30, 2008 -262.00M
March 31, 2008 -2.937B
Dec. 31, 2007 -427.00M
Sept. 30, 2007 33.00M
June 30, 2007 -13.88B
March 31, 2007 -616.00M
Dec. 31, 2006 285.00M
Sept. 30, 2006 -546.00M
June 30, 2006 1.892B
March 31, 2006 -1.903B
Dec. 31, 2005 -561.00M
Sept. 30, 2005 -1.098B
June 30, 2005 506.00M
March 31, 2005 -29.00M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Investing

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More

Advertisement

AZN Cash from Investing (Quarterly) Benchmarks

Companies
GlaxoSmithKline -579.33M
Amgen -1.813B
Celgene 45.00M

AZN Cash from Investing (Quarterly) Range, Past 5 Years

Minimum -3.777B Mar 2014
Maximum 603.00M Dec 2016
Average -999.68M

AZN Cash from Investing (Quarterly) Excel Add-In Codes

  • Metric Code: cash_investing
  • Latest data point: =YCP("AZN", "cash_investing")
  • Last 5 data points: =YCS("AZN", "cash_investing", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.